Prolyl oligopeptidase induces angiogenesis both in vitro and in vivo in a novel regulatory manner
Myöhänen, TT, Tenorio‐Laranga, J, Jokinen, B, Vázquez‐Sánchez, R, Moreno‐Baylach, MJ, García‐Horsman, JA, Männistö, PT
Published in British journal of pharmacology (01.08.2011)
Published in British journal of pharmacology (01.08.2011)
Get full text
Journal Article
Constitutive Ret signaling leads to long-lasting expression of amphetamine-induced place conditioning via elevation of mesolimbic dopamine
Kopra, Jaakko, Villarta-Aguilera, Marian, Savolainen, Mari, Weingerl, Samo, Myöhänen, Timo T., Rannanpää, Saara, Salvatore, Michael F., Andressoo, Jaan-Olle, Piepponen, T. Petteri
Published in Neuropharmacology (01.01.2018)
Published in Neuropharmacology (01.01.2018)
Get full text
Journal Article
Vascular endothelial growth factor C acts as a neurotrophic factor for dopamine neurons in vitro and in vivo
Piltonen, M, Planken, A, Leskelä, O, Myöhänen, T.T, Hänninen, A.-L, Auvinen, P, Alitalo, K, Andressoo, J.-O, Saarma, M, Männistö, P.T
Published in Neuroscience (29.09.2011)
Published in Neuroscience (29.09.2011)
Get full text
Journal Article
A prolyl oligopeptidase inhibitor, KYP-2047, reduces [alpha]-synuclein protein levels and aggregates in cellular and animal models of Parkinson's disease
Myohanen, TT, Hannula, MJ, Van Elzen, R, Gerard, M, Van Der Veken, P, Garcia-Horsman, JA, Baekelandt, V, Mannisto, PT, Lambeir, AM
Published in British journal of pharmacology (01.06.2012)
Published in British journal of pharmacology (01.06.2012)
Get full text
Journal Article
A prolyl oligopeptidase inhibitor, KYP‐2047, reduces α‐synuclein protein levels and aggregates in cellular and animal models of Parkinson's disease
Myöhänen, TT, Hannula, MJ, Van Elzen, R, Gerard, M, Van Der Veken, P, García‐Horsman, JA, Baekelandt, V, Männistö, PT, Lambeir, AM
Published in British journal of pharmacology (01.06.2012)
Published in British journal of pharmacology (01.06.2012)
Get full text
Journal Article